Insider-aankopen in gezondheidszorg
In de laatste 90 dagen meldden insiders in deze sector 63 aankoopen met eigen geld, samen $174.4M. Het vaakst gekocht: Prothena Corp Public Ltd Co (PRTA). Laatste melding: 10 nov 2026.
Aankopen, 90 dagen
63
Totaal gekocht
$174.4M
Hoogste score
VRCA · 10/10
Sinds begin
88
Meest gekochte gezondheidszorg-aandelen
| Aandeel | Aankopen | Samen |
|---|---|---|
| PRTA Prothena Corp Public Ltd Co | 8× | $9.2M |
| INBX Inhibrx Biosciences, Inc. | 5× | $5.8M |
| AVR Anteris Technologies Global Corp. | 3× | $11.7M |
| NTHI Neonc Technologies Holdings, Inc. | 3× | $636K |
| CV Capsovision, Inc | 2× | $10.0M |
| CTEV Claritev Corp | 2× | $3.6M |
| KURA Kura Oncology, Inc. | 2× | $2.4M |
| COO Cooper Companies, Inc. | 2× | $1.9M |
| ATEC Alphatec Holdings, Inc. | 2× | $1.3M |
| MDGL Madrigal Pharmaceuticals, Inc. | 1× | $35.0M |
Gratis account maken
Volg de sector: een melding zodra een insider hier koopt.
Recente aankopen
| Aandeel | Insider | Datum | Bedrag | Score |
|---|---|---|---|---|
| WW Ww International, Inc. | Lisa A Gavales, Stephen J Bye | 10 nov 2026 | $193K | 6/10 |
| STVN Stevanato Group S.P.A. | Donald E Morel Jr | 10 nov 2026 | $327K | 3/10 |
| PRTA Prothena Corp Public Ltd Co | William P Scully | 10 nov 2026 | $1.2M | 5/10 |
| ATEC Alphatec Holdings, Inc. | Keith Valentine | 10 nov 2026 | $243K | 3/10 |
| OBIO Orchestra Biomed Holdings, Inc. | Eric S Fain, Andrew Lawrence Taylor, David P Hochman, David Pacitti | 9 nov 2026 | $230K | 6/10 |
| SOPH Sophia Genetics Sa | Ross Muken, George Cardoza | 9 nov 2026 | $278K | 4/10 |
| NTHI Neonc Technologies Holdings, Inc. | Amir F Heshmatpour | 9 nov 2026 | $231K | 4/10 |
| MDGL Madrigal Pharmaceuticals, Inc. | Baker Bros. Advisors Lp / Baker Bros. Advisors (Gp) Llc / Baker Felix / Baker Julian / 667, L.P. / Baker Brothers Life Sciences Lp | 6 nov 2026 | $35.0M | 7/10 |
| KOD Kodiak Sciences Inc. | Baker Bros. Advisors Lp / 667, L.P. / Baker Bros. Advisors (Gp) Llc / Baker Brothers Life Sciences Lp / Baker Felix / Baker Julian | 6 nov 2026 | $24.3M | 7/10 |
| CVS Cvs Health Corp | Prem S Shah | 6 nov 2026 | $2.0M | 8/10 |
| CTEV Claritev Corp | Ares Management Llc / Asof Investment Management Llc / Ares Management Holdings L.P. / Ares Holdco Llc / Ares Management Corp / Ares Voting Llc / Ares Management Gp Llc / Ares Partners Holdco Llc, Ares Management Llc / Asof II Holdings I, L.P. / Asof II A (De) Holdings I, L.P. / Asof III Holdings I Lp | 27 okt 2026 | $3.4M | 6/10 |
| SRRK Scholar Rock Holding Corp | Srinivas Akkaraju | 27 okt 2026 | $12.0M | 7/10 |
| PRTA Prothena Corp Public Ltd Co | William P Scully | 26 okt 2026 | $1.2M | 5/10 |
| KRRO Korro Bio, Inc. | Lynx1 Capital Management Lp / Nichols Weston | 26 okt 2026 | $885K | 3/10 |
| RAPP Rapport Therapeutics, Inc. | Wendy B. Young, Steven M Paul, Paul M Silva, John Maraganore | 22 okt 2026 | $1.4M | 9/10 |
| PRTA Prothena Corp Public Ltd Co | William P Scully | 15 okt 2026 | $920K | 3/10 |
| INBX Inhibrx Biosciences, Inc. | Mark Lappe | 14 okt 2026 | $849K | 5/10 |
| PRTA Prothena Corp Public Ltd Co | William P Scully | 9 okt 2026 | $1.8M | 5/10 |
| AVR Anteris Technologies Global Corp. | L1 Capital Pty Ltd | 8 okt 2026 | $2.0M | 5/10 |
| AGMB Agomab Therapeutics Nv | Pierre Thadee Victor Kemula, David R Epstein, Tim Jasper Knotnerus | 7 okt 2026 | $267K | 6/10 |
| AVR Anteris Technologies Global Corp. | L1 Capital Pty Ltd | 6 okt 2026 | $6.7M | 7/10 |
| PRTA Prothena Corp Public Ltd Co | William P Scully | 6 okt 2026 | $857K | 4/10 |
| OM Outset Medical, Inc. | Braden Michael Leonard | 5 okt 2026 | $870K | 3/10 |
| XENE Xenon Pharmaceuticals Inc. | Thomas Patrick Kelly, Ian Mortimer | 1 okt 2026 | $1.7M | 8/10 |
| AVR Anteris Technologies Global Corp. | L1 Capital Pty Ltd | 1 okt 2026 | $3.0M | 6/10 |
| PRTA Prothena Corp Public Ltd Co | William P Scully | 30 sep 2026 | $1.4M | 6/10 |
| PRTA Prothena Corp Public Ltd Co | William P Scully | 29 sep 2026 | $890K | 4/10 |
| DMRA Damora Therapeutics, Inc. | Jennifer Jarrett | 28 sep 2026 | $253K | 4/10 |
| INBX Inhibrx Biosciences, Inc. | Mark Lappe | 28 sep 2026 | $999K | 4/10 |
| OFIX Orthofix Medical Inc. | Juniper Investment Company, Llc / Bartholdson John A. / Michas Alexis P | 23 sep 2026 | $2.7M | 5/10 |
| INBX Inhibrx Biosciences, Inc. | Jon Faiz Kayyem | 23 sep 2026 | $500K | 5/10 |
| CV Capsovision, Inc | Ching Hang Shen | 23 sep 2026 | $5.0M | 5/10 |
| PRTA Prothena Corp Public Ltd Co | William P Scully | 21 sep 2026 | $843K | 3/10 |
| CV Capsovision, Inc | Ching Hang Shen | 18 sep 2026 | $5.0M | 6/10 |
| COO Cooper Companies, Inc. | Lawrence Erik Kurzius | 17 sep 2026 | $549K | 5/10 |
| INBX Inhibrx Biosciences, Inc. | Jon Faiz Kayyem | 17 sep 2026 | $500K | 4/10 |
| ACOG Alpha Cognition Inc. | Opaleye Management Inc. | 16 sep 2026 | $1.1M | 4/10 |
| COO Cooper Companies, Inc. | Lawrence Erik Kurzius, Walter M Rosebrough Jr, Paul A Keel | 15 sep 2026 | $1.3M | 8/10 |
| NAMS Newamsterdam Pharma Co N.V. | Michael H. Davidson | 15 sep 2026 | $226K | 3/10 |
| NTHI Neonc Technologies Holdings, Inc. | Thomas C Chen, Keithly Garnett, Amir F Heshmatpour | 15 sep 2026 | $216K | 7/10 |